300142.SZ
Price:
$11.3
Market Cap:
$18.07B
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent e...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-11-12
Stock Exchange
SHZ
Ticker
300142.SZ
According to Walvax Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.66B. This represents a change of 5.84% compared to the average of 15.74B of the last 4 quarters.
The mean historical Enterprise Value of Walvax Biotechnology Co., Ltd. over the last ten years is 39.04B. The current 16.66B Enterprise Value has changed 4.17% with respect to the historical average. Over the past ten years (40 quarters), 300142.SZ's Enterprise Value was at its highest in in the September 2021 quarter at 95.86B. The Enterprise Value was at its lowest in in the March 2025 quarter at 14.31B.
Average
39.04B
Median
30.18B
Minimum
14.73B
Maximum
86.87B
Discovering the peaks and valleys of Walvax Biotechnology Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.37%
Maximum Annual Enterprise Value = 86.87B
Minimum Annual Increase = -52.04%
Minimum Annual Enterprise Value = 14.73B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 16.00B | -52.04% |
| 2023 | 33.36B | -45.26% |
| 2022 | 60.94B | -29.84% |
| 2021 | 86.87B | 50.55% |
| 2020 | 57.70B | 21.43% |
| 2019 | 47.52B | 76.63% |
| 2018 | 26.90B | -0.40% |
| 2017 | 27.01B | 83.37% |
| 2016 | 14.73B | -24.07% |
| 2015 | 19.40B | -36.19% |
The current Enterprise Value of Walvax Biotechnology Co., Ltd. (300142.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
36.77B
5-year avg
50.97B
10-year avg
39.04B
Walvax Biotechnology Co., Ltd.’s Enterprise Value is less than Shenzhen Kangtai Biological Products Co., Ltd. (17.96B), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.14B), less than Hybio Pharmaceutical Co., Ltd. (17.81B), greater than Fujian Cosunter Pharmaceutical Co., Ltd. (14.24B), greater than Beijing Aosaikang Pharmaceutical Co., Ltd. (14.00B), less than Shandong Buchang Pharmaceuticals Co., Ltd. (20.29B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.77B), less than Apeloa Pharmaceutical Co.,Ltd (18.74B), greater than Guangdong Zhongsheng Pharmaceutical Co., Ltd. (15.92B), greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (16.02B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 17.96B | $17.06B | |
| 18.14B | $19.15B | |
| 17.81B | $16.02B | |
| 14.24B | $14.05B | |
| 14.00B | $15.33B | |
| 20.29B | $17.25B | |
| 13.77B | $16.15B | |
| 18.74B | $19.30B | |
| 15.92B | $16.29B | |
| 16.02B | $14.74B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Walvax Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Walvax Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Walvax Biotechnology Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ)?
What is the 3-year average Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ)?
What is the 5-year average Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ)?
How does the current Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ) compare to its historical average?